Novus Therapeutics Inc
Change company Symbol lookup
Select an option...
NVUS Novus Therapeutics Inc
CSCO Cisco Systems Inc
CVX Chevron Corp
RF Regions Financial Corp
THG Hanover Insurance Group Inc
USB U.S. Bancorp
WFC Wells Fargo & Co
BAC Bank of America Corp
AAPL Apple Inc
ORGO Organogenesis Holdings Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Novus Therapeutics, Inc., formerly Tokai Pharmaceuticals, Inc., is a pharmaceutical company. The Company is focused on the acquisition, development, and commercialization of ear, nose, and throat products. It has two platforms: OP-01 Foam Platform and OP-02 Surfactant Program. OP-01 is developed with the intent to be used as a delivery vehicle for drugs treating ears, as well as the nasal and sinus cavities. OP-01 is currently being developed as an improved treatment option for acute otitis externa. OP-02 is a daily nasal spray that is designed to improve and maintain a healthy middle ear. OP-02 is being developed as a potential treatment option for patients with otitis media and Eustachian tube dysfunction. OP-02 is a combination drug product, which comprises two components: surfactant dipalmitoylphosphatidylcholine and a spreading agent cholesteryl palmitate. The product is sprayed through the nostrils toward the opening of the Eustachian tube at the back of the nasal cavity.

Postmarket

Last Trade
Delayed
$0.98
0.006 (0.62%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$0.974
Day's Change
0.0818 (9.17%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
1.03
Day's Low
0.8675
Volume
(Light)
Volume:
3,004,059

10-day average volume:
20,888,514
3,004,059
  • Prev Close
    0.8922
  • Today's Open
    0.8714
  • Day's Range
    0.8675-1.03
  • Avg Vol (10-day)
    20.9M
  • Last (time)
    4:00p ET 09/22/20
  • Last (size)
    10
  • 52-Wk Range
    0.25 - 1.45
    LowHigh
  • (03/20/20 - 05/28/20)
    32.83%
  • 168.7%
  • Market Cap
    22.6M
  • Shares Outstanding
    23.2M
  • -1.17
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.4
  • 34.72
  • (% of float 08/31/20)
    1.13

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.